4th International Eosinophil Symposium

要求为定于2005年5月25日至29日在瑞士伯尔尼大学医院举行的第四届国际嗜酸粒细胞双年研讨会和2007年第五届双年研讨会提供财政支持。这些两年一次的会议是在国际嗜酸性粒细胞协会（IES）的主持下举行的。2005年的会议将邀请41位受邀的全体发言人和另外120位与会者提交摘要，以供青年科学家的“前沿”口头报告和海报会议选择。会议于5月25日（星期三）开始，并于周日结束。5月29日。在与国际咨询委员会和IES执行委员会协商后，当地组委会准备了一个前沿的基础、转化和临床研究项目。研讨会为初级研究人员提供了口头和海报报告的绝佳机会，并举行了全体会议，讨论这一生物医学上重要、多样化和跨学科领域的最新进展。研讨会邀请嗜酸性粒细胞研究和相关领域的领导者从哮喘、过敏、肺病、胃肠道和寄生虫病的角度进行演讲，并包括新的Paul Erlich讲座，以及关于嗜酸性粒细胞研究未来方向的主题演讲。重点是嗜酸性粒细胞细胞，分子和免疫生物学的基本方面，结合嗜酸性粒细胞在正常生理和疾病发病机制中的作用的转化和临床研究。今年增加了嗜酸性粒细胞胃肠道疾病、嗜酸性粒细胞在组织重塑和纤维化中的作用、高嗜酸性粒细胞综合征的新致病方面以及抗嗜酸性粒细胞治疗策略的会议，包括对嗜酸性粒细胞生物学知识在药物中的应用的讨论

Financial support is requested for the 4th Biennial International Eosinophil Symposium, scheduled for May 25-29, 2005 at University Hospital, Bern, Switzerland, and the 5th Biennial Symposium in 2007. These biennial conferences are held under the auspices of the International Eosinophil Society (IES). The 2005 meeting will host 41 invited plenary speakers and an additional -120 participants who are solicited to submit abstracts for selection for "Cutting Edge" oral presentation and poster sessions by young scientists. The conference begins with a reception/orientation on Wed., May 25 and finishes on Sun., May 29. A cutting edge program of basic, translational, and clinical research has been prepared by the Local Organizing Committee in consultation with the International Advisory Committee, and the Executive Committee of the IES. The Symposium provides outstanding opportunities for oral and poster presentations by junior investigators, and plenary sessions on the most recent advances in this biomedically important, diverse and interdisciplinary field. The Symposium features invited talks by leaders in eosinophil research and allied fields from the perspectives of asthma, allergy, pulmonary, gastrointestinal and parasitic diseases, and includes a new Paul Erlich Lectureship, and Keynote Addresses on future directions in eosinophil research. The focus is on both basic aspects of eosinophil cellular, molecular and immunobiology, integrated with translational and clinical investigations of the roles of eosinophils in normal physiology and disease pathogenesis. Sessions on eosinophilic GI diseases, eosinophils in tissue remodeling and fibrosis, new pathogenic aspects of hypereosinophilic syndromes, and anti-eosinophil treatment strategies have been added this year, including discussions on applications of knowledge of eosinophil biology to drug discovery for eosinophil-associated diseases. The Symposium is a highly interactive, workshop-like, forum for both oral and poster presentations of cutting edge abstracts by younger scientists, particularly graduate students, postdoctoral fellows, and junior faculty. Afternoons are purposefully unscheduled to allow opportunities for scientific discussions, and social/recreational activities in and around the conference venue. The 4"' Symposium covers major themes on: (1) Regulation of Eosinophil Development, Functional Maturation (Activation and Inhibition), and Death, (2) Animal Models of Eosinophil Diseases, (3) Roles of Eosinophils in Gastrointestinal Diseases, (4) Eosinophils in Innate Immunity, (5) Eosinophil Regulation of Th2 Immune Responses, (6) Hosinophiis in Tissue Remodeling and Fibrosis, (7) New Pathogenic Aspects of Hypereosinophilic Syndromes, and (8) Anti-eosinophil Treatment Strategics. The central goal of this conference is to provide a highly interactive forum for scientific exchange and collaboration amongst junior and senior scientists in the fields of allergy, immunology, hematology, and cancer as relates to the biology and functions of the eosinophil in normal host physiology in health and pathophysiology in disease.